Publications by authors named "Robert Raju"

10Publications

A phase I dose-escalation study to a predefined dose of a transforming growth factor-β1 monoclonal antibody (TβM1) in patients with metastatic cancer.

Authors:
Allen Cohn Michael M Lahn Kristen E Williams Ann L Cleverly Celine Pitou Sunil K Kadam Mark W Farmen Durisala Desaiah Robert Raju Paul Conkling Donald Richards

Int J Oncol 2014 Dec 26;45(6):2221-31. Epub 2014 Sep 26.

Tyler Cancer Center, Tyler, TX, USA.

View Article and Find Full Text PDF
December 2014

R-CHOP with iodine-131 tositumomab consolidation for advanced stage diffuse large B-cell lymphoma (DLBCL): SWOG S0433.

Authors:
Jonathan W Friedberg Joseph M Unger W Richard Burack Ajay K Gopal Robert N Raju Auayporn P Nademanee Mark S Kaminski Hongli Li Oliver W Press Thomas P Miller Richard I Fisher

Br J Haematol 2014 Aug 18;166(3):382-9. Epub 2014 Apr 18.

James P. Wilmot Cancer Center, University of Rochester, Rochester, NY, USA.

View Article and Find Full Text PDF
August 2014

A first in human, safety, pharmacokinetics, and clinical activity phase I study of once weekly administration of the Hsp90 inhibitor ganetespib (STA-9090) in patients with solid malignancies.

Authors:
Jonathan W Goldman Robert N Raju Gregory A Gordon Iman El-Hariry Florentina Teofilivici Vojo M Vukovic Robert Bradley Michael D Karol Yu Chen Wei Guo Takayo Inoue Lee S Rosen

BMC Cancer 2013 Mar 25;13:152. Epub 2013 Mar 25.

UCLA Medical Center, Suite 600, 2020 Santa Monica Blvd, Santa Monica, CA 90404, USA.

View Article and Find Full Text PDF
March 2013

Paired tumor and normal whole genome sequencing of metastatic olfactory neuroblastoma.

Authors:
Glen J Weiss Winnie S Liang Tyler Izatt Shilpi Arora Irene Cherni Robert N Raju Galen Hostetter Ahmet Kurdoglu Alexis Christoforides Shripad Sinari Angela S Baker Raghu Metpally Waibhav D Tembe Lori Phillips Daniel D Von Hoff David W Craig John D Carpten

PLoS One 2012 23;7(5):e37029. Epub 2012 May 23.

Virginia G. Piper Cancer Center Clinical Trials at Scottsdale Healthcare (VGPCC), Scottsdale, Arizona, United States of America.

View Article and Find Full Text PDF
October 2012

Randomized, phase II trial of pemetrexed and carboplatin with or without enzastaurin versus docetaxel and carboplatin as first-line treatment of patients with stage IIIB/IV non-small cell lung cancer.

Authors:
Mark A Socinski Robert N Raju Thomas Stinchcombe Darren M Kocs Linda S Couch David Barrera Steven R Rousey Janak K Choksi Robert Jotte Debra A Patt Phillip O Periman Howard R Schlossberg Charles H Weissman Yunfei Wang Lina Asmar Sharon Pritchard Jane Bromund Guangbin Peng Joseph Treat Coleman K Obasaju

J Thorac Oncol 2010 Dec;5(12):1963-9

Multidisciplinary Thoracic Oncology Program, Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, North Carolina 27599-7305, USA.

View Article and Find Full Text PDF
December 2010

Results of a phase 2 study of bortezomib in patients with relapsed or refractory indolent lymphoma.

Authors:
Nicholas Di Bella Raymond Taetle Kathryn Kolibaba Thomas Boyd Robert Raju David Barrera Ernest W Cochran Philip Y Dien Roger Lyons Peter J Schlegel Svetislava J Vukelja Julie Boston Kristi A Boehm Yunfei Wang Lina Asmar

Blood 2010 Jan 19;115(3):475-80. Epub 2009 Nov 19.

US Oncology Research Inc, The Woodlands, TX, USA.

View Article and Find Full Text PDF
January 2010

Pemetrexed in relapsed small-cell lung cancer and the impact of shortened vitamin supplementation lead-in time: results of a phase II trial.

Authors:
Mark A Socinski Robert N Raju Marcus Neubauer David A Smith Donald A Richards Michael Savin Robert L Ruxer Craig H Reynolds Feng Zhan Jane L Bromund Ruqin Chen Coleman Obasaju

J Thorac Oncol 2008 Nov;3(11):1308-16

University of North Carolina, Lineberger Comprehensive Cancer Center, Chapel Hill, North Carolina 27599-7305, USA.

View Article and Find Full Text PDF
November 2008

Phase I study of a 3-drug regimen of gemcitabine/cisplatin/pemetrexed in patients with metastatic transitional cell carcinoma of the urothelium.

Authors:
Thomas E Hutson Svetislava Vukelja Daniel Atienza Sanjay Awasthi Robert Delaune Margaret Deutsch Philip Y Dien Thomas F Gregory Michael J Kolodziej Joseph J Muscato Robert N Raju Robert L Ruxer Stephanie Mull Des Ilegbodu Karen Hood Steven Nicol William Berry

Invest New Drugs 2008 Apr 31;26(2):151-8. Epub 2008 Jan 31.

US Oncology Research, Inc., Genitourinary Oncology Program, Houston, TX, USA.

View Article and Find Full Text PDF
April 2008

Randomized phase III study of trastuzumab, paclitaxel, and carboplatin compared with trastuzumab and paclitaxel in women with HER-2-overexpressing metastatic breast cancer.

Authors:
Nicholas Robert Brian Leyland-Jones Lina Asmar Robert Belt Des Ilegbodu David Loesch Robert Raju Elizabeth Valentine Robert Sayre Melody Cobleigh Kathy Albain Cecelia McCullough Lea Fuchs Dennis Slamon

J Clin Oncol 2006 Jun;24(18):2786-92

US Oncology Research Inc, Houston, TX, USA.

View Article and Find Full Text PDF
June 2006

Results of a phase II multicenter trial of weekly docetaxel and gemcitabine as first-line therapy for patients with advanced non-small cell lung cancer.

Authors:
Marcus A Neubauer David H Garfield Paul R Kuerfler Robert N Raju Deborah L Lindquist Edward W Soo Myrna Khan Kristi A Boehm Lina Asmar

Lung Cancer 2005 Jan;47(1):121-7

US Oncology, Inc., 12941 North Freeway, Suite 700, Houston, TX 77060, USA.

View Article and Find Full Text PDF
January 2005